Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The elongation factor Tu–aminoacyl-tRNA complex is a central protein–nucleic acid assembly in bacterial translation elongation. EF-Tu is a highly conserved bacterial GTPase that binds aminoacyl-tRNA (aa-tRNA) in its GTP-bound form, forming a ternary complex (EF-Tu–GTP–aa-tRNA) that delivers the correct aa-tRNA to the ribosomal A-site according to the mRNA codon sequence. Upon correct codon–anticodon pairing, EF-Tu hydrolyzes GTP, undergoes a conformational change, and releases the tRNA into the ribosome for peptide bond formation, before being recycled in a GTP-dependent manner with the help of EF-Ts. EF-Tu is an essential and ancient translation factor, and its complex with aa-tRNA is a validated antibacterial drug target, with several natural product antibiotics inhibiting this pathway by locking EF-Tu to the tRNA and impairing protein synthesis. Because of its essential role in bacterial viability and highly conserved structure, but significant divergence from eukaryotic homologs, EF-Tu is considered to be an attractive, though not entirely risk-free, therapeutic target for new antibacterial agents.
Inhibition of EF-Tu GTPase activity; Stabilization of EF-Tu:tRNA complex, preventing release of aminoacyl-tRNA; Blocking binding of EF-Tu to the ribosome; Preventing recycling of EF-Tu (by inhibiting EF-Ts-mediated GDP-GTP exchange)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongation factor Tu–aminoacyl-tRNA complex (EF-Tu:aa-tRNA complex).